General Manager, Asia-Pacific

Iterative Scopes; Singapore; On-site; SGD 250,000 - 350,000; Full time

Job summary

Iterative Health is seeking a General Manager for APAC, anchoring Singapore as the regional hub. You will own P&L, build the market from the ground up, and lead strategy across APAC in collaboration with global leadership.

You will recruit and develop GM-level talent, manage sponsor relationships, and drive performance against ambitious regional goals. Travel across APAC will be required (25%+). This is a founding seat with high autonomy.

Qualifications

• Must have prior GM/ Country Manager or equivalent P&L ownership experience.
• Background in healthcare, clinical research, CRO, or life sciences is required.
• Experience hiring and developing other GMs or senior operators.

Responsibilities

• Own APAC P&L and regional performance across markets.
• Build Singapore clinical trial infrastructure and partner hospital networks.
• Design and roll out a regional hub-and-spoke operating model.
• Shape country-specific operating models and cadence.

Skills

P&L ownership

Stakeholder management

Healthcare experience

Growth leadership

Travel readiness

Education

Bachelor's degree in life sciences or business

Job description

Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes.

We built a leading performance-driven network of 100+ sites across the US, Europe, India, and Australia, conducting research directly in the communities where care is delivered across gastrointestinal, hepatology, obesity, and cardiology. By combining deep clinical trial expertise with cutting-edge AI, we connect sponsors' scientific ambitions with high-performing research teams that expedite and expand access to novel therapeutics for patients in need. Today, Iterative Health is headquartered in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.

We're launching operations in APAC and we're looking for a General Manager to lead the strategy, buildout, and scaling of our operations. This is a founding seat with a mandate to shape and run a region from the ground up, launching operations in Singapore as a hub for the region, plus supporting and growing our early footprint in India and Australia. We envision launching a regional hub and spoke model with Singapore as the hub, supporting patient recruitment and clinical trial execution across neighboring countries (e.g., Indonesia, Malaysia, etc.)

You will operate at whatever altitude a given market requires. Where a country lead is already in place, you will set direction, resourcing, and cadence while they own execution; where no one is yet in seat, you will build the site network, sponsor relationships, and operate rhythm directly.

You'll have full P&L ownership of a region, a direct line to the Global COO, and real authority to design the org as you go rather than inherit one. This is a high accountability executive leadership role for someone who has built a market or business from scratch and knows how to operate with real autonomy.

Where You'll Drive Impact

Regional Launch & P&L Ownership

• Own full P&L accountability for the APAC region as it's built out across all markets, including revenue growth, operating performance, and resource allocation.
• Own buildout of Singapore clinical trial infrastructure, overseeing execution alongside our partnered local hospital system
• Own buildout of regional hub and spoke model, including strategy, logistics, roll out timing, and execution
• Design and tailor our operating model for each country
• Build the region's operating cadence, consistent with our broader company operating model.
• Balance near-term market execution with the investments and capabilities required to build a durable, scalable regional business.

Establishing New Market Power

• Establish deep relationships with Private Investigators to drive engagement and and buy-in to embedding clinical research alongside clinical care
• Establish deep relationships with our global and local sponsor partners to drive buy-in to this new model and shape the required operating rhythm to make trials successful together
• Establish new markets from the ground up and build a repeatable playbook for market entry.
• Identify the gaps between where each market is today and where it needs to be at scale, directing the org structure, systems, and processes to close them.

Stakeholder & Sponsor Leadership

• Serve as the senior point of contact and escalation for sponsors across APAC.
• Represent APAC to the Global COO and executive leadership on performance and investment decisions.
• Work with Life Sciences and global leadership to align on sponsor priorities across the region.
• Represent the region externally with sponsors and partners as a credible senior voice for the business.
• Perform other tasks as assigned.

What You Bring to the Team

• Prior experience as a GM, Country Manager, or equivalent P&L owner in at least one market.
• Background in healthcare, clinical research, CRO, or life sciences
• Direct experience building a market or business from scratch. Experience hiring and developing other GMs or senior operators.
• Comfortable with full P&L accountability while building the team and infrastructure from the ground up.
• Strong stakeholder management skills, with the ability to represent a region credibly to executive leadership and external partners.
• Willingness to travel regularly across APAC markets (25%+).

Preferred qualifications

• Familiarity with clinical trial operations, site management, and sponsor-side dynamics in at least one APAC market
• Experience leading or supporting M&A
• Time in top-tier consulting (e.g., McKinsey, BCG, Bain)

What Success Looks Like

• Sponsors and local affiliates have a single, trusted IH counterpart in CEE they proactively engage throughout the study lifecycle.
• Study kickoffs are structured, well-documented, and set clear expectations for all parties from day one.
• IH's value proposition is current, credible, and consistently communicated to regional sponsor audiences.
• Site performance, risks, and pull-through actions are reported accurately and acted on in weekly alignment cadences.
• Sponsor satisfaction and retention improve measurably, and IH's share of new studies within existing sponsor relationships grows.
• IH is recognized by regional sponsors as a preferred network partner in CEE.

At Iterative Health, we're actively working towards creating an environment that is representative of the diversity of patients our technology serves. We are focused on building an equitable and inclusive culture, and by extension, hiring process. If you require any accommodations to make the application process or interviewing experience more accessible to you, please contact [e-mail].